BLRX

BioLineRX
BLRX

Overview Fund Activity

29 hedge funds and large institutions have $2.12M invested in BioLineRX in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
–
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
10
Closed
3
Calls
$451K
Puts
$219K
Net Calls
+$232K
Net Calls Change
+$312K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$748K
2
PAM
2
PVG Asset Management
Colorado
$97.1K
3
Qube Research & Technologies (QRT)
3
Qube Research & Technologies (QRT)
United Kingdom
$63.5K
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$36.1K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$62.8K

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$204K
3
Citadel Advisors
3
Citadel Advisors
Florida
$38K
4
XT
4
XTX Topco
Cayman Islands
$0
5
LPL Financial
5
LPL Financial
California
$158K
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$471 -$13.2K -224 -97%
TCM
27
Tradewinds Capital Management
Washington
$314 – – –
SM
28
Sabby Management
Florida
– -$382K -5,250 Closed
XT
29
XTX Topco
Cayman Islands
– -$42.5K -584 Closed
HF
30
HRT Financial
New York
– -$21K -293 Closed
1
2